A detailed history of Pier Capital, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Pier Capital, LLC holds 61,018 shares of LNTH stock, worth $5.52 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
61,018
Previous 61,459 0.72%
Holding current value
$5.52 Million
Previous $4.93 Million 35.71%
% of portfolio
1.0%
Previous 0.77%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$77.7 - $123.62 $34,265 - $54,516
-441 Reduced 0.72%
61,018 $6.7 Million
Q2 2024

Aug 07, 2024

BUY
$58.87 - $83.05 $1.82 Million - $2.57 Million
30,961 Added 101.52%
61,459 $4.93 Million
Q1 2024

May 02, 2024

BUY
$51.07 - $68.26 $1.56 Million - $2.08 Million
30,498 New
30,498 $1.9 Million
Q4 2022

Feb 15, 2023

SELL
$48.76 - $77.67 $23,112 - $36,815
-474 Reduced 0.55%
85,612 $4.36 Million
Q3 2022

Nov 15, 2022

BUY
$61.42 - $86.29 $5.29 Million - $7.43 Million
86,086 New
86,086 $6.05 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.